KR100891294B1 - Cosmetic compositions containing complex plant extracts - Google Patents

Cosmetic compositions containing complex plant extracts Download PDF

Info

Publication number
KR100891294B1
KR100891294B1 KR1020070088364A KR20070088364A KR100891294B1 KR 100891294 B1 KR100891294 B1 KR 100891294B1 KR 1020070088364 A KR1020070088364 A KR 1020070088364A KR 20070088364 A KR20070088364 A KR 20070088364A KR 100891294 B1 KR100891294 B1 KR 100891294B1
Authority
KR
South Korea
Prior art keywords
extract
activity
licorice
raw material
ethanol
Prior art date
Application number
KR1020070088364A
Other languages
Korean (ko)
Other versions
KR20090022750A (en
Inventor
염교선
김종귀
윤태영
김영부
Original Assignee
주식회사 아이피어리스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 아이피어리스 filed Critical 주식회사 아이피어리스
Priority to KR1020070088364A priority Critical patent/KR100891294B1/en
Publication of KR20090022750A publication Critical patent/KR20090022750A/en
Application granted granted Critical
Publication of KR100891294B1 publication Critical patent/KR100891294B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/79Schisandraceae (Schisandra family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 한약재의 복합 추출물 (오미자, 상백피, 감초)로 항산화, 미백에 도움을 주는 화장품 원료 조성물에 관한 것으로 오미자, 상백피, 감초 각각의 추출물보다 복합 추출물이 활성이 뛰어나다는 것을 확인하였다. 이 복합 추출물이 활성산소 (자유라디칼)를 소거하고 티로시나아제 활성을 억제함으로써 그 효과를 나타내는 것이다. 더불어 항균, 항염 효과를 가진다.The present invention relates to a cosmetic raw material composition that helps antioxidant and whitening as a complex extract (Schisandra chinensis, Schisandra chinensis, Licorice) of the herbal medicines, and confirmed that the extract of the extract of Schizandra chinensis (Schisandra chinensis) was superior to each extract. This complex extract exhibits its effect by scavenging free radicals (free radicals) and inhibiting tyrosinase activity. In addition, it has antibacterial and anti-inflammatory effects.

한약재, 화장료, 항산화, 미백, 오미자, 상백피, 감초 Herbal Medicine, Cosmetics, Antioxidant, Whitening, Schisandra chinensis, Lettuce, Licorice

Description

복합 한약재 추출물을 이용한 화장품 원료{Cosmetic compositions containing complex plant extracts} Cosmetic raw materials using complex herbal extracts {Cosmetic compositions containing complex plant extracts}

본 발명은 화장품 원료 조성물에 관한 것으로, 특히 오미자, 상백피, 감초 복합 추출물 (OSG)을 주성분으로 하는 화장품 원료 조성물에 관한 것이다. 또한, 상기 조성물의 티로시나아제 활성 저해능을 확인하여 미백제로서의 용도에 관한 것이며, 자유 라디칼 소거 및 활성산소 소거능이 우수함을 확인하고 이 효능을 가지는 위 추출물의 항산화제로서의 용도에 관한 것이다.BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to cosmetic raw material compositions, and in particular to cosmetic raw material compositions comprising Schizandra chinensis, Morus bark, Licorice complex extract (OSG) as a main component. In addition, it relates to the use as a whitening agent by identifying the tyrosinase activity inhibitory ability of the composition, and relates to the use as an antioxidant of the above extract having the excellent free radical scavenging and active oxygen scavenging ability and having this effect.

피부는 자외선이 조사되면 세포내의 물질인 티로신이 활성효소인 티로시나아제에 의해 산화작용을 일으켜 도파키논으로 전환되고 최종적으로는 멜라닌이 되어 피부에 색소침착을 일으킨다. 멜라닌색소의 증가를 막아 피부의 색소침전을 막기 위해 널리 사용되고 있는 미백성분으로는 알부틴 등이 있다. When the ultraviolet light is irradiated, tyrosine, an intracellular substance, is oxidized by tyrosinase, an active enzyme, converted into dopakinone, and finally becomes melanin, causing pigmentation on the skin. Arbutin is a whitening ingredient widely used to prevent pigmentation of the skin by preventing the increase of melanin pigment.

산소는 호흡을 하는데 필요하지만 노화, 관절염, 암 등 다양한 질병을 일으키는데 직간접적으로 관여하고 있다. 이것은 활성화된 산소종을 말하는데 이것은 자유라디칼로 세포의 면역 반응, 세포 내 전자 전달계에서의 에너지 생성 반응, 자외선, 스트레스, 세균 등에 의해서 생성된다. 또한 체내에서 생성되면 세포를 파괴하거나 주름 형성, 피부암, 아토피성 피부염, 여드름 등 여러 가지 문제를 일으킨다고 알려져 있다. 항산화 물질은 동, 식물계에 널리 분포되어 있으며 과일, 채소에 많은 페놀성 화합물, 플라보노이드, 토코페롤, 비타민 C 와 같은 물질들이 지질의 산화를 지연시키거나 방지하여 노화를 방지시킨다. Oxygen is required to breathe, but is directly or indirectly involved in various diseases such as aging, arthritis, and cancer. It refers to activated oxygen species, which are free radicals that are produced by cellular immune responses, energy-generating responses in the intracellular electron transport system, ultraviolet light, stress, and bacteria. In addition, when produced in the body is known to cause various problems such as cell destruction, wrinkle formation, skin cancer, atopic dermatitis, acne. Antioxidants are widely distributed in the copper and plant systems, and many phenolic compounds in fruits and vegetables, such as flavonoids, tocopherols, and vitamin C, prevent or slow down the oxidation of lipids.

본 발명의 목적은 알부틴보다 미백효과가 우수하며, 동시에 항산화 효과를 가진 천연물질을 원료로 하는 화장품 원료 조성물을 제공하는 것이다. An object of the present invention is to provide a cosmetic raw material composition having a whitening effect is superior to arbutin, and at the same time as a raw material with an antioxidant effect.

상기 본 발명의 목적은 오미자, 상백피, 감초 복합 추출물 (OSG)을 주성분으로 하는 화장품 원료 조성물에 의해 달성된다. The object of the present invention is achieved by a cosmetic raw material composition containing Schizandra chinensis, Morus bark, Licorice complex extract (OSG) as a main component.

추출 방법은 물, 에탄올, 또는 부틸렌글리콜, 또는 이들의 혼합용매를 사용하여 상온 내지 용매의 비점 사이의 온도에서 상압 추출 또는 초고압추출하는 방법을 사용한다. The extraction method uses a method of atmospheric pressure extraction or ultrahigh pressure extraction at a temperature between normal temperature and the boiling point of the solvent using water, ethanol or butylene glycol, or a mixed solvent thereof.

오미자, 상백피, 감초의 비율은 건조된 원재료 중량을 기준으로 중량비로 6-15 중량부: 8-20중량부: 14-35중량부가 바람직하다. The ratio of Schisandra chinensis, Morus bark and Licorice is preferably 6-15 parts by weight: 8-20 parts: 14-35 parts by weight based on the weight of the dried raw material.

본 발명의 추출물은 티로시나아제와 친화성이 높은 물질로서, 피부에 침투되면 효소인 티로시나아제에 결합하여 티로신과의 반응을 억제한다. 멜라닌색소의 증가를 막아 피부의 색소침전을 막기 위해 널리 사용되고 있는 미백성분인 알부틴에 비해 티로시나아제 저해효과가 훨씬 크다.The extract of the present invention is a substance having high affinity with tyrosinase, and when penetrated into the skin, it binds to the tyrosinase enzyme and inhibits the reaction with tyrosine. Tyrosinase inhibitory effect is much higher than that of arbutin, a whitening ingredient widely used to prevent pigmentation of the skin by preventing the increase of melanin pigment.

이하 본 발명을 실시예를 통해 보다 상세하게 설명한다.Hereinafter, the present invention will be described in more detail with reference to Examples.

실시예 1. 50% 에탄올을 이용한 가열 추출법Example 1 Heat Extraction Method Using 50% Ethanol

오미자 15g, 상백피 20g, 감초 35g을 50% 에탄올 700㎖에 넣고 끓인 후 1/10로 농축하였다. 15 g of Schizandra chinensis, 20 g of lettuce, and 35 g of licorice were put in 700 ml of 50% ethanol, and concentrated to 1/10.

실시예 2. 50% 에탄올을 이용한 상온 침지 추출법 Example 2. Room temperature immersion extraction using 50% ethanol

오미자 15g, 상백피 20g, 감초 35g을 50% 에탄올 700㎖에 넣고 상온에서 24시간 동안 교반 추출하였다. 추출물은 1/10로 농축하였다.15 g of Schizandra chinensis, 20 g of lettuce, and 35 g of licorice were added to 700 ml of 50% ethanol and extracted by stirring at room temperature for 24 hours. The extract was concentrated to 1/10.

실시예3. 열수추출법 Example 3. Hydrothermal extraction

오미자 15g, 상백피 20g, 감초 35g을 증류수 700㎖에 넣고 끓인 후 1/10로 농축하였다.15 g of Schizandra chinensis, 20 g of lettuce, and 35 g of licorice were put in 700 ml of distilled water, and then boiled and concentrated to 1/10.

실시예4. 부틸렌글리콜 (butylene glycol)과 에탄올을 이용한 상온 침치 추출법 Example 4. Extraction Method of Room Temperature Using Butylene Glycol and Ethanol

오미자 15g, 상백피 20g, 감초 35g을 부틸렌글리콜과 95% 에탄올의 비율을 3:7로 한 용매 700㎖에 넣고 상온에서 24시간 동안 교반 추출하였다. 추출물을 최대한 농축시켰다.15 g of Schizandra chinensis, 20 g of lettuce, and 35 g of licorice were added to 700 ml of a solvent having a ratio of butylene glycol and 95% ethanol at 3: 7, followed by extraction with stirring at room temperature for 24 hours. The extract was concentrated to the maximum.

실시예5. 50% 에탄올을 이용한 초고압 추출법 (cold isotatic press, CIP 추출법) Example 5. Ultra high pressure extraction method using 50% ethanol (cold isotatic press, CIP extraction method)

오미자 6g, 상백피 8g, 감초 14g을 50% 에탄올 280㎖에 넣고 4,000bar의 압력을 가하여 추출 (초고압 멸균기에 의해 추출)하여 그 양을 1/10로 농축하였다.6 g of Schizandra chinensis, 8 g of lettuce, and 14 g of licorice were added to 280 ml of 50% ethanol, and extracted by applying a pressure of 4,000 bar (extracted by an ultrahigh pressure sterilizer) and the amount was concentrated to 1/10.

실시예6. 부틸렌글리콜 (butylenes glycol)과 에탄올을 이용한 초고압 추출법 (supercritical fluid system, SCF 추출법) Example 6. Supercritical fluid system (SCF extraction) using butylene glycol and ethanol

오미자 6g, 상백피 8g, 감초 14g을 부틸렌글리콜과 95% 에탄올의 비율을 3:7로 한 용매 280㎖에 넣고 4,000bar의 압력을 가하여 추출 (초고압 멸균기에 의해 추출)하여 최대한 농축시켰다.6 g of Schisandra chinensis, 8 g of lettuce, and 14 g of licorice were added to 280 ml of a solvent having a ratio of butylene glycol and 95% ethanol at 3: 7, and extracted by applying a pressure of 4,000 bar (extracted by an ultrahigh pressure sterilizer) to maximize concentration.

시험예 Test Example

시험방법 Test Methods

6가지 추출법에 의해 얻은 추출물은 색깔과 향 침전물의 상태를 고려하여 화 장품에 가장 적합한 추출물을 선별한다. 선별한 추출물을 농도별로 생리활성 효과를 평가, 확인하여 제품 적용한다.Extracts obtained by the six extraction methods select the most suitable extracts for cosmetics, taking into account the condition of color and flavor precipitates. Selected extracts are evaluated by confirming their physiological activity effects and applying the product.

시험예1Test Example 1 . . DPPHDPPH 에 의한 On by 자유라디칼Free radical 소거법에 따른 환원 활성 Reduction Activity by the Elimination Method

1,1-디페닐-2-피크릴-히드라진(DPPH, D9132, Sigma, USA)은 화학적으로 안정화된 프리라디칼을 가지고 있는 수용성 물질로 515nm~520nm 부근에서 최대 흡광도를 가지며, 항산화 활성이 있는 물질과 만나면 전자를 내어주면서 라디칼 (DPPH)이 소멸되고 색깔이 변한다. 화학적으로 안정성 있는 DPPH은 여러 종의 항산화 성분이 내재된 추출물, 음료와 오일, 순수 페놀화합물 등의 항산화 효과를 분석 할 수 있다. 이 실험은 DPPH로 먼저 산화를 개시한 후 시료에 의해서 라디칼에 대한 소거되는 활성을 알아보기 위한 실험이다. DPPH를 메탄올에 용해시킨 0.2mM의 DPPH 용액 1㎖에 각 농도의 실시예 1의 복합추출물 시료 및 각 개별 추출물 시료를 첨가하였다. 실온에서 10분간 반응시킨 후 UV (Varian, Germany)로 517nm에서 흡광도를 측정하였다. 대조군은 시료액과 DPPH용액 대신 메탄올을 넣어 보정값을 얻는다. 자유라디칼 소거율은 아래의 식에 따라 계산하였다. 1,1-diphenyl-2-picryl-hydrazine (DPPH, D9132, Sigma, USA) is a water-soluble substance with chemically stabilized free radicals, which has a maximum absorbance at around 515 nm to 520 nm and has antioxidant activity. When it meets with, it releases electrons and the radical (DPPH) disappears and its color changes. Chemically stable DPPH can analyze the antioxidant effects of extracts, beverages and oils, and pure phenolic compounds inherent in various antioxidants. This experiment is to determine the activity of eliminating radicals by sample after initiating oxidation with DPPH. To 1 ml of 0.2 mM DPPH solution in which DPPH was dissolved in methanol, a composite extract sample and each individual extract sample of each concentration were added. After reacting at room temperature for 10 minutes, the absorbance was measured at 517 nm by UV (Varian, Germany). In the control group, methanol is added instead of the sample solution and the DPPH solution to obtain a correction value. Free radical scavenging rate was calculated according to the following equation.

소거율 (%) = (대조군의 흡광도-시험군의 흡광도) / 대조군의 흡광도 X 100% Clearance = (absorbance of control group-absorbance of test group) / absorbance of control group X 100

대조군은 6-히드록시-2,5,6,8-테트라메틸크로만-2-카르복실산(Trolox, 97%, Aldrich, USA)를 사용하였다. Trolox는 비타민 E 유사체로 항산화 효능이 뛰어난 물질이다. 시험에서는 에탄올에 0.1% 농도로 희석한 후, 활성의 50%를 기준으로 하여 Trolox와 비슷하거나 높은 값을 가지는 시료가 활성이 좋은 것으로 간주했다. The control group used 6-hydroxy-2,5,6,8-tetramethylchroman-2-carboxylic acid (Trolox, 97%, Aldrich, USA). Trolox is a vitamin E analogue that is highly antioxidant. In the test, samples diluted with 0.1% concentration in ethanol and similar to or higher than Trolox based on 50% of activity were considered to have good activity.

그 결과를 하기 표 1 및 도 1에 게시하였다. The results are published in Table 1 below and in FIG. 1.

실시예 1의 추출물은 1000ppm, 500ppm에서 대조군보다 활성이 높았다 Extract of Example 1 was more active than the control at 1000ppm, 500ppm

시험2Exam 2 . . SODSOD 활성 측정 Active measurement

활성산소 (reactive oxygen species) 소거활성 (SOD activity)은 크산틴/크산틴 옥시다아제(Sigma, USA) 효소반응에 의한 활성 산소 발생계를 이용하여 활성 산소에 의한 NBT (nitrobluetetrazolium, Sigma, USA)의 산화에 의한 흡광도 변화를 측정하여 평가한다. 0.05mM Na2CO3 (Mw 105.99, Yakuri Pure Chemicals Co., Ltd, Japan) 2.4㎖, 3mM xanthine (X-0626, Sigma, USA) 0.1㎖, 3mM EDTA (E-5134, Sigma, USA) 0.1㎖, BSA (bovine serum albumin, A-7906, Sigma, USA) 0.1㎖, 0.75mM NBT (N-6875, Sigma, USA) 0.1㎖, 각 시료(시험예 1과 동일) 0.1㎖를 넣고 잘 혼합한 후 25℃에서 10분간 정치시켰다. 크산틴 옥시다아제(X-4376, Sigma, USA) 0.1㎖를 넣고 25℃에서 20분간 반응시킨 후에 6mM CuCl2 (Mw 170.48, Daejung Chemicals & Metals Co., LTD, Korea) 0.1㎖를 넣어 반응을 정지시키고 UV-VIS 분광광도계(Cary 50 Bio, Varian, Germany)로 560nm에서 흡광도를 측정하였다. 대조군은 시료 대신 정제수를 넣으며, 크산틴 옥시다아제 대신에 정제수를 넣어 색보정값을 얻는다. 소거율은 DPPH 라디칼 소거율에 사용된 식에 따라 계산하였다. 대조군은 비타민C (l-ascorbic acid, A-1417, Sigma, USA)를 사용하였다. 활성은 60 ~ 80%로 기준하였으며 이와 비슷하거나 높은 값을 가지는 경우 활성이 높은 것으로 간주했다. 결과는 표 1 및 도 2에 게시하였다. Reactive oxygen species SOD activity is the oxidation of NBT (nitrobluetetrazolium, Sigma, USA) by active oxygen using an active oxygen generation system by xanthine / xanthine oxidase (Sigma, USA) enzyme reaction. Absorbance change by the measurement is measured and evaluated. 0.05mM Na2CO3 (Mw 105.99, Yakuri Pure Chemicals Co., Ltd, Japan) 2.4 ml, 3 mM xanthine (X-0626, Sigma, USA) 0.1 ml, 3 mM EDTA (E-5134, Sigma, USA) 0.1 ml, BSA (bovine serum albumin , A-7906, Sigma, USA) 0.1 ml, 0.75 mM NBT (N-6875, Sigma, USA) 0.1 ml, 0.1 ml of each sample (same as Test Example 1) and mixed well, and left to stand at 25 ° C for 10 minutes. I was. Add 0.1 ml of xanthine oxidase (X-4376, Sigma, USA) and react for 20 minutes at 25 ° C.2 (Mw 170.48, Daejung Chemicals & Metals Co., LTD, Korea) 0.1 ml was added to stop the reaction, and the absorbance was measured at 560 nm with a UV-VIS spectrophotometer (Cary 50 Bio, Varian, Germany). In the control group, purified water was added instead of the sample, and purified water was added instead of xanthine oxidase to obtain a color correction value. Scavenging rate was calculated according to the formula used for DPPH radical scavenging rate. Vitamin C (l-ascorbic acid, A-1417, Sigma, USA) was used as a control. The activity was based on 60% to 80% and was considered to be high when the value was similar or high. The results are published in Table 1 and FIG.

SOD유사활성 결과도 1000, 500ppm에서는 대조군보다 활성이 높았다. SOD-like activity was also higher than that of the control at 1000 and 500 ppm.

시험3Exam 3 . 티로시나아제 활성 저해 시험(. Tyrosinase activity inhibition test ( InIn vitroin vitro 티로시나아제  Tyrosinase inhibitioninhibition assayassay ))

티로시나아제는 인체 내의 멜라닌 생합성 경로에서 가장 중요한 초기 속도 결정단계에 관여하는 효소로서 많은 미백 성분이 이 효소를 억제하는 작용기전을 가지고 있다. 이 시험은 시료의 티로시나아제 효소의 활성을 저해하는 정도를 평가하는 방법이다. 각 시료(시험예 1과 동일) 0.9㎖, 0.1M 인산염 완충액 (pH 6.5) 1.0㎖, 1.5mM L-티로신 (T8566, Sigma, USA) 1.0㎖을 넣은 후, 37℃에서 10분간 유지시켰다. 버섯 티로시나아제 (T3824, Sigma, USA) 0.1㎖를 첨가하여 37℃에서 10분간 반응시킨 후, UV-VIS 분광광도계 (Cary 50 Bio, Varian, Germany)를 사용하여 480nm에서 흡광도를 측정하였다. 티로시나아제 활성 저해율은 아래의 식에 따라 계산하였다. TyrosinaseIs an enzyme involved in the most important early rate determining step in the melanin biosynthesis pathway in human body. This test is a method of evaluating the degree of inhibition of the activity of a tyrosinase enzyme in a sample. 0.9 ml of each sample (same as Test Example 1), 1.0 ml of 0.1 M phosphate buffer (pH 6.5), and 1.0 ml of 1.5 mM L-tyrosine (T8566, Sigma, USA) were added and then maintained at 37 ° C. for 10 minutes. After 0.1 ml of mushroom tyrosinase (T3824, Sigma, USA) was added and reacted at 37 ° C. for 10 minutes, the absorbance was measured at 480 nm using a UV-VIS spectrophotometer (Cary 50 Bio, Varian, Germany). The tyrosinase activity inhibition rate was calculated according to the following formula.

티로시나아제 활성 저해율 (%) = ( 대조군의 흡광도-시험군의 흡광도 ) / 대조군의 흡광도 X 100% Inhibition of tyrosinase activity = (absorbance of control group-absorbance of test group) / absorbance of control group X 100

대조군은 2% 알부틴을 사용하였다. 활성은 60 ~ 80%로 기준하였으며 이와 비슷하거나 높은 값을 가지는 경우 활성이 높은 것으로 간주했다. 결과를 하기 표 1 및 도 3에 게시하였다. 2% arbutin was used as a control. The activity was based on 60% to 80% and was considered to be high when the value was similar or high. The results are posted in Table 1 below and in FIG. 3.

500, 1,000ppm에서 알부틴보다 활성이 높았다. 50, 100ppm에서도 활성은 50% 이상이었다.The activity was higher than that of arbutin at 500 and 1,000 ppm. The activity was 50% or more even at 50 and 100 ppm.

시험4Exam 4 . 리폭시게나아제(. Lipoxygenase ( Lipoxigenase)Lipoxigenase) 활성 억제에 의한 항염시험 Anti-inflammatory test by inhibition of activity

지질의 과산화물 생성억제효과는 리놀레인산(L2376, Sigma, assay 98%, USA)를 기질로 사용하여 불포화 지방산의 산화과정에 따른 중간생성물질인 과산화물가를 측정하여 확인한다. 리놀렌인산 1㎖, 3000, 5000, 7000, 10000ppm 각 농도의 실시예 1의 복합추출물 시료 및 각 개별 추출물 시료 0.1㎖, lipoxidase (L7395, Sigma, USA) 0.9㎖를 시간, 속도를 일정하게 잘 혼합하여 25℃에서 10분간 반응시킨 후 20%w/v 트리클로로아세트산(TCA, Junsei Chemicals Co., Ltd, Japan) 0.5㎖, 60%w/v Thiobarbituric acid (TBA, T5500, Sigma, USA)를 넣어 혼합하여 끓는 물 속에서 10분간 가열하여 발색시킨 후 냉각시켰다. 냉각된 시료에 부탄올 2㎖를 넣고 20초간 보텍스 교반기(vortexmixer)로 혼합한 후 3,500rpm에서 5분간 원심분리하여 상층액을 얻었다. UV-VIS 분광광도계(Cary 50 Bio, Varian, Germany)를 사용하여 535nm에서 흡광도를 측정하였다. 활성저해율은 아래의 식에 따라 계산하였다. The inhibitory effect of lipid peroxide production was confirmed by measuring the peroxide value, an intermediate product of oxidation of unsaturated fatty acids, using linoleic acid (L2376, Sigma, assay 98%, USA) as a substrate. 1 ml, linolenic acid, 3000, 5000, 7000, 10000ppm of the composite extract sample of Example 1 at each concentration, 0.1ml of each individual extract sample, 0.9ml of lipoxidase (L7395, Sigma, USA) After reacting for 10 minutes at 25 ° C, mix 20% w / v trichloroacetic acid (TCA, Junsei Chemicals Co., Ltd, Japan) 0.5ml and 60% w / v Thiobarbituric acid (TBA, T5500, Sigma, USA) After heating for 10 minutes in boiling water, the color was cooled. 2 mL of butanol was added to the cooled sample, mixed with a vortex mixer for 20 seconds, and centrifuged at 3,500 rpm for 5 minutes to obtain a supernatant. Absorbance was measured at 535 nm using a UV-VIS spectrophotometer (Cary 50 Bio, Varian, Germany). The inhibition rate was calculated according to the following equation.

리폭시게나아제 활성 저해율 (%) = ( 대조군의 흡광도 - 시험군의 흡광도 ) / 대조군의 흡광도 X 100% Inhibition of lipoxygenase activity = (absorbance of control group-absorbance of test group) / absorbance of control group X 100

그 결과는 표 1 및 도 4 에 게시하였다. 1000ppm에서 58.66%의 활성을 보였다. 대조군은 활성이 아주 좋은 추출물로 기준하였으며 10,000ppm에서 70 ~ 90%의 활성을 나타내는 것이다.The results are published in Table 1 and FIG. 4. The activity was 58.66% at 1000 ppm. The control group was based on a very good extract and shows 70 to 90% of its activity at 10,000 ppm.

시험5Exam 5 . 항균 효과. Antimicrobial effect

균은 그람 양성 균 Staphylococcus aureus KCTC3881, 그람 음성 균 Pseudomonas aeruginosa KCTC 1750, 효모 Candida albicans KCTC 7965, 곰팡이 Aspergillus niger KCTC 6196을 사용하였으며, 배지는 세균용은 tryptic soy agar (TSA, Difco, USA), 진균용은 potato dextrose agar (PDA, Difco, USA)를 사용하고 희석액은 0.85% NaCl saline을 사용하였다. 세균은 37℃ 에서 24시간 배양하고, 진균은 25℃ 에서 48 ~ 72시간 배양하여 관찰하였다. 배지 디스크 확산법으로 항균/항진균 효과를 확인하였다. 시험 전 MIC (minimum inhibition concentration)를 구하여 적용하였다. 결과를 표 1 및 도 5에 게시하였다. The fungus used Gram-positive bacteria Staphylococcus aureus KCTC3881, Gram-negative bacteria Pseudomonas aeruginosa KCTC 1750, yeast Candida albicans KCTC 7965, and fungus Aspergillus niger KCTC 6196. The potato dextrose agar (PDA, Difco, USA) was used and the diluent was 0.85% NaCl saline. Bacteria were incubated at 37 ° C for 24 hours, and fungi were observed at 25 ° C for 48 to 72 hours. The antibacterial / antifungal effect was confirmed by the medium disk diffusion method. Before the test, MIC (minimum inhibition concentration) was calculated and applied. The results are posted in Table 1 and FIG. 5.

진균에 대해서는 활성을 보이지 않았으며, 세균에 대해서는 항균력을 가지고 있었다. 그람 음성, 양성 모두에 대해서 항균력을 가지고 있었으며, 음성보다는 양성쪽에 조금 더 항균력이 있는 것으로 나타났다.It was not active against fungi and had antimicrobial activity against bacteria. It had antimicrobial activity against both Gram-negative and positive, and showed a little more antimicrobial activity on the positive side than negative.

시험6Exam 6 . . PhotoPhoto -- hemolysishemolysis ofof RBCRBC assayassay (적혈구의  Of red blood cells 광용혈Photohemolysis 시험) exam)

RBC에 UV를 조사하여 용혈을 인위적으로 일으킴과 동시에 추출물을 대조군과 처리군으로 나누어 시험하였을 때 용혈 억제율을 확인하는 방법으로 항산화 효과를 확인하는 시험이다. RBC artificially caused hemolysis by irradiation with UV, and extract was divided into control and treatment groups to test the anti-oxidative effect by checking the inhibition rate of hemolysis.

0.05%에서는 적혈구가 용해되어 0.02% 농도까지만 시험하였다. 10 ~ 30%의 광용혈 억제율을 확인하였다. ROS를 방어하는 활성은 0.02%에서 28.5%였고, 0.01%에서 10.4%였다. 그 이하 추출물 농도에서는 10%이하의 활성을 가졌다.At 0.05%, red blood cells were lysed and tested only at a concentration of 0.02%. The photohemolysis inhibition rate of 10-30% was confirmed. ROS defense activity was 0.02% to 28.5% and 0.01% to 10.4%. At the extract concentration below that, it had an activity of 10% or less.

시험7Exam7 . . MelanogenesisMelanogenesis inhibitioninhibition assayassay ( ( 세포내의Intracellular 멜라닌 생성 저해 시험) Melanin production inhibition test)

세포배양 시 세포 내의 멜라닌 생성양을 공시료액과 비교하는 시험법이다. Murine melanoma (B-16 F1) 세포를 10% FBS (fetal bovine serum)이 함유된 DMEM 배지에 5 > 103 cells/96well 농도로 접종한 후 10% CO2, 37℃에서 배양하였다. 24시간 배양 후 배지를 제거하고 시료가 0.05%, 0.02%, 0.01%, 0.002%, 0.001% 함유된 배지로 교체한 후 24시간 배양하였다. 시료의 농도 범위는 MTT assay를 이용한 독성 실험을 통해 결정하였다. 4일 배양 후 배지를 제거한 세포는 PBS (phosphated buffer saline)로 세척하고, 이것을 트립신으로 처리하여 세포를 회수하였다. 회수된 세포는 hematocytometer를 이용하여 세포수를 측정하였다. 5 > 106 cells은 1M 수산화나트륨액 (NaOH 용액) 1ml에 희석한 후 100?에서 30분간 가열하고, 13,000rpm에서 20분간 원심 분리한 후, 상등액은 405nm에서 흡광도를 측정하였다. MTT assay에 의해서 독성을 일으키지 않는 최대 농도를 구하였다. 최대 0.05%의 농도이며 시험한 농도는 0.001, 0.002, 0.01, 0.02, 0.05%로 하였다. 대조군으로 알부틴을 함께 시험하였으며, 알부틴의 농도는 0.05, 0.02, 0.01, 0.03, 0.001%로 하였다. 결과를 도 6 및 도 7에 도시하였다. It is a test method to compare the amount of melanin production in cells with a blank sample during cell culture. Murine melanoma (B-16 F1) cells were placed in DMEM medium containing 10% FBS (fetal bovine serum) 5> 10310% CO after inoculation at cells / 96well concentration2, And incubated at 37 ℃. After culturing for 24 hours, the medium was removed, and the sample was replaced with a medium containing 0.05%, 0.02%, 0.01%, 0.002%, and 0.001%, and then cultured for 24 hours. The concentration range of the sample was determined by the toxicity test using the MTT assay. After 4 days of culture, the cells from which the medium was removed were washed with PBS (phosphated buffer saline) and treated with trypsin to recover the cells. Recovered cells were counted using a hematocytometer. 5> 106The cells were diluted in 1 ml of 1 M sodium hydroxide solution (NaOH solution), heated at 100 ° C for 30 minutes, centrifuged at 13,000 rpm for 20 minutes, and the supernatant was measured for absorbance at 405 nm. The maximum concentration which does not cause toxicity by MTT assay was calculated | required. The concentration was 0.05% at maximum, and the tested concentrations were 0.001, 0.002, 0.01, 0.02, and 0.05%. Arbutin was tested as a control, and arbutin concentrations were 0.05, 0.02, 0.01, 0.03, and 0.001%. The results are shown in FIGS. 6 and 7.

멜라닌 생성 억제율을 측정한 결과 농도 0.05%에서는 80%의 멜라닌이 감소하는 확인하였다. 알부틴의 70% 정도 감소보다 효과가 우수했다. 0.01% 농도에서는 거의 2배의 활성을 가지며, 0.002% 이하에서는 그 효과가 아주 우수함을 확인하였다(도 6). 도 7은 실험상 멜라닌 합성이 억제된 상태를 사진 촬영한 것이다. 멜라 닌 형성을 저해하는 현상을 육안 관찰할 수 있다. 알부틴과 OSG는 농도 의존적으로 멜라닌 형성을 저해하는 활성이 크다 (도 7, 추출물 1, 2와 비교시).As a result of measuring melanin production inhibition rate, it was confirmed that 80% of melanin was decreased at the concentration of 0.05%. The effect was better than a 70% reduction in arbutin. At 0.01% concentration, it had almost twice the activity, and it was confirmed that the effect was very excellent at 0.002% or less (FIG. 6). 7 is a photograph of a state in which melanin synthesis is suppressed experimentally. The phenomenon that inhibits melanin formation can be visually observed. Arbutin and OSG have a large concentration-dependent activity that inhibits melanin formation (compared to FIGS. 7, extracts 1 and 2).

시험8Exam 8 . . 과색소침착증에서In hyperpigmentation 미백효과평가시험( Whitening effect evaluation test EfficacyEfficacy evaluationevaluation onon hyperhyper melanosismelanosis ))

인체적용 피부 멜라닌, 홍반 수치를 측정하는 방법으로 Derma-spectrometer (Dermalab., Netherlands)를 이용하여 시험 부위를 측정한다. 18 ~ 60세 성인 남녀 20명을 대상으로 추출물을 첨가한 제품을 하루 2회, 색소 침착이 있는 부위에 도포하고 시간 경과에 따른 색소 감소율을 확인하였다 (이중맹검법으로 실시). Human skin melanin and erythema levels are measured using a Derma-spectrometer (Dermalab., Netherlands). Twenty 18 to 60-year-old adult male and female extracts were added twice a day to pigmented areas and the rate of pigment reduction was confirmed over time (double blind method).

초기에서 7일 경과마다 멜라닌 수치의 감소율을 측정한 것으로 시간 경과에 따라 감소율이 증가할수록 미백 활성이 있는 것으로 간주한다. 결과를 도 8에 도시하였다. The rate of decrease of melanin was measured every 7 days from the beginning, and it is considered to have whitening activity as the rate of decrease increases over time. The results are shown in FIG.

1주에서 2주 사이 피시험자들에게는 자외선 노출이 장시간 있었으며 따라서 멜라닌 수치가 증가하였다. 즉 감소율이 저하된 것을 확인하였다. 대조군의 경우를 보면 초기에 멜라닌 수치 감소율에 비해 자외선 노출 후 회복하는데 시간이 오래 걸렸으며 처음 감소율보다 28일 경과 후 감소율이 적었다. 반면 추출물을 넣은 시험군의 경우, 초기 감소율보다 최종 감소율이 높았으며 자외선 노출 후 회복력이 대조군보다 좋았다. 따라서 대조군보다 OSG추출물의 멜라닌 감소효과가 우수한 것으로 생각된다.Between 1 and 2 weeks, subjects had prolonged UV exposure and therefore increased melanin levels. That is, it was confirmed that the reduction rate was lowered. In the case of the control group, it took longer to recover after exposure to UV rays than the rate of melanin reduction, and the decrease was less than 28 days after the initial decrease. On the other hand, in the test group containing the extract, the final reduction rate was higher than the initial reduction rate, and the recovery after UV exposure was better than the control group. Therefore, the melanin reduction effect of the OSG extract is thought to be superior to the control.

표1. 복합 추출물과 개별 추출물의 활성 비교. Schizandra chinensis Baillon :O, Morus alba L. :S, and Glycyrrhiza glabra L. :G. Pa : P. aeruginosa KCTC1750 , Sa : S. aureus KCTC3881. (n=5) Table 1. Comparison of activity of complex and individual extracts. Schizandra chinensis Baillon : O, Morus alba L .: S, and Glycyrrhiza glabra L .: G. Pa : P. aeruginosa KCTC1750 , Sa : S. aureus KCTC3881 . (n = 5)

Figure 112007063674142-pat00001
Figure 112007063674142-pat00001

+: 활성의 정도, ?+: 희미한 활성+: Degree of activity,? +: Faint activity

O: 오미자 추출물 S: 상백피 추출물 G:감초 추출물 O: Schisandra chinensis extract S: Morus bark extract G: Licorice extract

OSG: 오미자, 상백피, 감초 복합 추출물(실시예1의 추출물) OSG: Schisandra chinensis, Morus bark, Licorice Complex Extract (Extract of Example 1)

활성을 가지는 추출물을 화장품 원료로서 사용할 때에는 제품의 안전성을 고려하지 않을 수 없다. 추출물의 색이 제품에 영향을 주거나 혹은 차후 변색이 되는 유무, 추출물의 향취, 독성 등이 제품은 물론 피부에 적용했을 때 문제가 될 수 있다. 따라서 여러 가지 추출법에 의한 OSG 추출물을 색깔, 활성, 독성을 비교하였고 가장 적합하다고 생각되는 것은 50% 에탄올을 사용하여 가열 추출한 방법이었다 (실시예1). 세포 독성은 0.05%이하에서는 없으며, In vitro, In vivo시험에서도 0.05% 이하에서의 활성을 확인하였으며 추출물의 활성은 우수하였다. 오미자, 상백피, 감초를 각각을 추출하여 시험한 결과보다 복합 추출한 것이 활성이 우수하였고 여러 가지 기능을 복합적으로 가지고 있었다. 특히 미백활성은 대조군인 알부틴보다도 효과가 크며, 항산화 효과, 자유라디칼이나 활성산소종을 소거하는 능력도 뛰어난 것을 확인하였다. 또한 항균력도 가지고 있으며, 항염 활성을 가지고 있어서 피부트러블개선에도 효과적일 것으로 생각된다. 이 추출물은 개별적인 추출물의 활성보다 복합추출물로 적용했을 때 활성이 더 크다는 것과, 적은 양으로도 최대의 효과를 가질 수 있다. 따라서, 복합 기능성 화장품의 원료로 적합하게 사용할 수 있다. When using an active extract as a cosmetic raw material, the safety of the product must be considered. Whether the color of the extract affects the product or becomes discolored later, the smell of the extract, or the toxicity can be a problem when applied to the skin as well as the product. Therefore, OSG extracts by various extraction methods were compared in color, activity and toxicity, and the most suitable method was heat extraction using 50% ethanol (Example 1). Cytotoxicity was not less than 0.05%, activity was confirmed at less than 0.05% in vitro, in vivo test and the activity of the extract was excellent. The extracts of Schisandra chinensis, Morus bark and Licorice were more active than the test results, and they had various functions. In particular, the whitening activity was more effective than the arbutin control group, it was confirmed that the antioxidant effect, the ability to eliminate free radicals and free radicals. It also has antibacterial activity and anti-inflammatory activity, so it is thought to be effective for skin trouble improvement. This extract is more active when applied as a complex extract than the activity of the individual extract, and can have the maximum effect in a small amount. Therefore, it can use suitably as a raw material of composite functional cosmetics.

도 1은 본 발명의 복합추출물의 농도에 따른 프리라디칼 소거효과를 나타낸 그래프이다. 1 is a graph showing the free radical scavenging effect according to the concentration of the complex extract of the present invention.

도 2는 본 발명의 복합추출물의 농도에 따른 활성산소 소거효과를 나타낸 그래프이다. Figure 2 is a graph showing the active oxygen scavenging effect according to the concentration of the complex extract of the present invention.

도 3은 본 발명의 복합추출물의 농도에 따른 티로시나아제 활성 억제율은 나타낸 그래프이다. Figure 3 is a graph showing the inhibition rate of tyrosinase activity according to the concentration of the complex extract of the present invention.

도 4는 본 발명의 복합추출물의 농도에 따른 항염 효과를 나타낸 그래프이다. Figure 4 is a graph showing the anti-inflammatory effect according to the concentration of the complex extract of the present invention.

도 5는 본 발명의 복합 추출물과 개별 추출물의 항균력 시험결과를 나타낸 사진이다( 사진에서 O: 오미자 추출물 S: 상백피 추출물 G:감초 추출물 OSG: 오미자, 상백피, 감초 복합 추출물(실시예1의 추출물))Figure 5 is a photograph showing the antimicrobial activity test results of the composite extract and the individual extract of the present invention (O: Schisandra chinensis extract S: Morus extract G: Licorice extract OSG: Schisandra chinensis, Morus extract, licorice complex extract (extract of Example 1) )

도 6은 알부틴과 본 발명의 복합 추출물의 멜라닌 합성 억제율을 비교한 그래프이다. Figure 6 is a graph comparing the melanin synthesis inhibition rate of arbutin and the complex extract of the present invention.

도 7은 알부틴과 본 발명의 복합 추출물의 멜라닌 합성이 억제된 상태를 사진 촬영한 것이다. Figure 7 is a photograph of a state in which melanin synthesis of arbutin and the complex extract of the present invention is suppressed.

도 8은 본 발명의 복합 추출물의 멜라닌/홍반 감소율을 나타낸 그래프이다. 8 is a graph showing the melanin / erythema reduction rate of the complex extract of the present invention.

Claims (5)

오미자, 상백피 및 감초의 복합추출물로 구성되는 화장품 원료 조성물에 있어서, 오미자, 상백피, 및 감초의 혼합비는 건조된 원재료 중량을 기준으로 6-15 중량부: 8-20중량부: 14-35중량부인 것을 특징으로 하는 화장품 원료 조성물.In the cosmetic raw material composition consisting of a complex extract of Schisandra chinensis, Morus bark and Licorice, the mixing ratio of Schisandra chinensis, Morus bark, and Licorice is 6-15 parts by weight: 8-20 parts: 14-35 parts by weight based on the weight of dried raw materials Cosmetic raw material composition, characterized in that. 제 1항에 있어서, 상기 추출물은 물, 에탄올, 또는 부틸렌글리콜, 또는 이들의 혼합용매를 사용하여 추출한 추출물인 것을 특징으로 하는 화장품 원료 조성물.The cosmetic raw material composition according to claim 1, wherein the extract is an extract extracted using water, ethanol, butylene glycol, or a mixed solvent thereof. 제 2항에 있어서, 상기 추출물은 물과 에탄올의 혼합용매를 사용하여 추출한 추출물인 것을 특징으로 하는 화장품 원료 조성물.The cosmetic raw material composition according to claim 2, wherein the extract is an extract extracted using a mixed solvent of water and ethanol. 제 3항에 있어서, 상기 물과 에탄올의 혼합용매의 에탄올 농도는 50%인 것을 특징으로 하는 화장품 원료 조성물. 4. The cosmetic raw material composition according to claim 3, wherein the ethanol concentration of the mixed solvent of water and ethanol is 50%. 삭제delete
KR1020070088364A 2007-08-31 2007-08-31 Cosmetic compositions containing complex plant extracts KR100891294B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020070088364A KR100891294B1 (en) 2007-08-31 2007-08-31 Cosmetic compositions containing complex plant extracts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070088364A KR100891294B1 (en) 2007-08-31 2007-08-31 Cosmetic compositions containing complex plant extracts

Publications (2)

Publication Number Publication Date
KR20090022750A KR20090022750A (en) 2009-03-04
KR100891294B1 true KR100891294B1 (en) 2009-04-06

Family

ID=40692566

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070088364A KR100891294B1 (en) 2007-08-31 2007-08-31 Cosmetic compositions containing complex plant extracts

Country Status (1)

Country Link
KR (1) KR100891294B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210026550A (en) 2019-08-30 2021-03-10 아이큐어 주식회사 Cosmetic materials with excellent anti inflammation, antioxidant and skin whitening, Manufacturing method thereof and cosmetics containing the same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101896609B1 (en) 2015-07-23 2018-09-07 동국대학교 산학협력단 Cosmetics composition for skin whitening comprising schizandra chinensis seed extract

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950016692A (en) * 1993-12-21 1995-07-20 한동근 Method for preparing purified lettuce extract and whitening cosmetics containing same
KR20010077652A (en) * 2000-02-07 2001-08-20 정찬복 Compositions for whitening cosmetics
KR20020001931A (en) * 2000-06-20 2002-01-09 임병철 The cosmetic product containing phellodendri cortex extract and/or schizandrae fructus extract which have anti-acne activity
KR20060098480A (en) * 2005-03-03 2006-09-19 임교빈 Formation of oil-soluble licorice extract including whitening bioactive materials

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950016692A (en) * 1993-12-21 1995-07-20 한동근 Method for preparing purified lettuce extract and whitening cosmetics containing same
KR20010077652A (en) * 2000-02-07 2001-08-20 정찬복 Compositions for whitening cosmetics
KR20020001931A (en) * 2000-06-20 2002-01-09 임병철 The cosmetic product containing phellodendri cortex extract and/or schizandrae fructus extract which have anti-acne activity
KR20060098480A (en) * 2005-03-03 2006-09-19 임교빈 Formation of oil-soluble licorice extract including whitening bioactive materials

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210026550A (en) 2019-08-30 2021-03-10 아이큐어 주식회사 Cosmetic materials with excellent anti inflammation, antioxidant and skin whitening, Manufacturing method thereof and cosmetics containing the same

Also Published As

Publication number Publication date
KR20090022750A (en) 2009-03-04

Similar Documents

Publication Publication Date Title
Sapkota et al. Antioxidant and antimelanogenic properties of chestnut flower extract
Rodrigues et al. Medicago spp. extracts as promising ingredients for skin care products
Onar et al. Elastase, tyrosinase and lipoxygenase inhibition and antioxidant activity of an aqueous extract from Epilobium angustifolium L. leaves
Ebrahimzadeh et al. Antioxidant and free radical scavenging activities of culinary-medicinal mushrooms, golden chanterelle Cantharellus cibarius and Angel's wings Pleurotus porrigens
Lourith et al. Antioxidant activities and phenolics of Passiflora edulis seed recovered from juice production residue
WO2011018885A1 (en) Preparation for external application to skin, skin whitening agent, antioxidant agent, and anti-aging agent
Jo et al. Radical scavenging activities of tannin extracted from amaranth (Amaranthus caudatus L.)
CN112493480B (en) Antioxidant composition and application thereof
TWI466686B (en) Whitening agents, anti-aging agents and antioxidants, and whitening endermic agents, anti-aging and anti-skin external oxidation method for producing a skin external preparation of
Saad et al. Evaluation of anti-melanogenesis and free radical scavenging activities of five Artocarpus species for cosmeceutical applications
Westfall et al. Antioxidant, UV Protection, and Antiphotoaging Properties of Anthocyanin-Pigmented Lipstick Formulations.
KR102330845B1 (en) A composition for antioxiation and antiinflammation comprising aronia fermented broth and Reed young leave extract
KR100891294B1 (en) Cosmetic compositions containing complex plant extracts
Biworo et al. The effect of dayak onion (Eleutherine palmifolia (L.) merr) tuber extract against erythema and melanin index on rat (Rattus norvegicus) skin induced by acute UV
Kim et al. Hot water leaves extracts of Zizyphus jujube exert antioxidative effects in vitro and cytotoxicity in human cancer cell lines
KR100949926B1 (en) Funetional cosmetic composition containing herb medicine extract, having antiphlogistic, antioxidantal, whitening and anti-microbial effect
KR20230039369A (en) Health functional stick jelly using rose and chrysanthemum extracts
KR101966755B1 (en) Composition for skin-lightening or antioxidant containing extract of Jeju camellia mistletoe
KR101921903B1 (en) Composition for antioxidation or whitening containing 21-O-angeloyltheasapogenol E3 from green tea seed
Manikandan et al. In vitro antioxidant activity of extracts of Psidium guajava leaves
Kim et al. The antioxidation effect of Salsola komarovii extract and its influence on cell bio activity
KR20160101578A (en) Functional health food composition and mathod for manufacturing the same
Adeel et al. Utilization of Colored Extracts for the Formulation of Ecological Friendly Plant-Based Green Products. Sustainability 2022, 14, 11758
KR20200090573A (en) A composition for antioxidating and antiinflammation comprising extracts of red ginseng and aronia melanocarpa
Kurniawansyah et al. The Natural Antioxidant Activity of Black Mulberry and its Others Function

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130118

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20140310

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20160122

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20170303

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20180302

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20190218

Year of fee payment: 11